Navigation Links
Diamond's Retirement Study Finds Companies Ill-Prepared to Meet Baby Boomers' Health and Wealth Needs
Date:3/4/2008

.

-- 46% say they could not afford a medical emergency, yet only 21% have

disability insurance.

What can companies take away from these findings? Banks, insurance companies, and financial advisory firms traditionally focused on managing specific risk characteristics-banks dealt with market risk and income risk, insurance carriers with mortality risk and morbidity risk, and financial advisors with longevity risk and market risk. But boomers need products that are more integrated, products that take into account how one type of risk affects another, according to the study.

Diamond's analysis finds that some consumer needs cut across multiple segments, such as consumer education and understanding risk. But in general, baby boomers are best served through a segmented approach.

Companies Need to Pick up the Pace

"For companies, it means being able to view retirement from two perspectives, simultaneously," said Tom Weakland, Managing Partner of Diamond's Healthcare practice. "Healthcare, financial services, and insurance firms should take a broad view of the overall retirement market, looking across industry lines. At the same time, the vast differences among consumers and their needs should drive companies to remain intensely focused on targeted market segments."

Companies that succeed in the retirement space will have four distinguishing traits that will help set them apart:

-- Defined role in the emerging market -- Trying to be all things to all

people is unlikely to be an effective strategy.

-- Tangible commitment to be a leader in the retirement marketplace --

Dedicated resources and capital are required to stake a claim in the

retirement market.

-- Alignment across the organization -- Delivering the breadth of products

and services retiring boomers expect requires collaboration and

cooperation, not corporate silos.

-- Demonstrated commitment
'/>"/>

SOURCE Diamond Management & Technology Consultants, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Hospital Association President Gary Carter Announces Retirement
2. BWMC President and CEO Announces Retirement
3. AXA Equitable Life Insurance Co. Hires William McDermott to Lead Corporate Retirement Planning Business
4. NAMI Statement on U.S. Senator Pete Domenici Retirement
5. Retirement Living TV Presents Sex, Drugs and Rock N Roll
6. Retirement Residents Return Home
7. ACS Launches Product to Help Employers Navigate Health Choices For Employees Entering Retirement Years
8. DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer
9. Andy Ambrose Joins MassMutuals Institutional Sales Team for Retirement Services
10. Construction Begins on Los Angeles First New Continuing Care Retirement Community Facility in Over a Decade
11. USA TODAY to Report Special Series "Turning 62: The Retirement Boom Begins"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...ies support providers in discussing health care co...As health care costs continue to rise, many employ...o their employees through higher premiums or cost-... and coinsurance. To help consumers better underst...viders, such as primary care physicians, specialis...
(Date:12/1/2008)...Medicare Prescription Drug Enrollment Period Is Ha... WASHINGTON, Dec. 1 The...nt period is nearly halfway over - running from No...nt period is an opportunity for seniors to change ... currently enrolled or for those not enrolled in a...
(Date:12/1/2008)...Dec. 1 Sciton introduces ProLipo,...a high-powered laser system,for ablating and melt... and,tissue tightening. ProLipo PLUS combines 10...timal body sculpting results. Frequently used as ...o be utilized as a standalone procedure,for patie...
(Date:12/1/2008)...R HONORED FOR CAREER OF SCIENTIFIC DISCOVERY IN MO... The Radiologic Society of North Am...th its "Outstanding Researcher of The Year" Award,...o has made original significant contributions to t...rch. Dr. Weissleder is Professor at Harvard Medic...
Breaking Medicine News(10 mins):Health News:Don't Know How Much an X-Ray Costs You? Highmark Network Providers Will Begin Having Conversations With Highmark Members About Their Actual Cost of Care 2Health News:Don't Know How Much an X-Ray Costs You? Highmark Network Providers Will Begin Having Conversations With Highmark Members About Their Actual Cost of Care 3Health News:Don't Know How Much an X-Ray Costs You? Highmark Network Providers Will Begin Having Conversations With Highmark Members About Their Actual Cost of Care 4Health News:Radio Interview Opportunity: Important News for Seniors 2Health News:Sciton Introduces ProLipo PLUS(TM), the Most Robust Laser-Assisted Lipolysis System Available 2Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 2Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 3
...ccessful cloning has been a dream come true for th...he U.S. Food and Drug Administration is expected t...unce soon that milk // from cloned animals, as wel... Canada holds the credit when it comes to cloning...
...u may expect your partner to inform you of his/her...e a legal stand on this. Even horrifying is the fa...to protect you // from the virus. The Wellington D...the charges of criminal nuisance against Justin Da...
...botic surgery could finally prove to be an answer ...the disease. Surgical treatment of prostate cancer...pain, scarring and a // reduction in the post-oper...s the second leading cause of death among American...
...rdasil is the new cervical vaccine developed by Sa... in its phase III trial, the vaccine is given in t...essful. The company is // to apply for a license t...lloma virus infection and also genital warts, whic...
Other Medicine News:Health News:Ruling On Non Disclosure Of HIV Positive Status Is Not Ethical 2Health News:Complete Robotic Surgery To Revolutionize Surgical Treatment of Prostate Cancer 2Health News:Gardasil vaccine for cervical cancer 2
(Date:11/25/2008).... 25 Proteolix, Inc., a,leader in...cs that target,protein degradation pathways in ca...t data from two ongoing Phase 2 clinical trials of...d at the upcoming 50th Annual Meeting of the,Amer...the first in a new class,of specific proteasome i...
(Date:11/25/2008)...l Trial to Assess Survival of Patients Receiving L...able Hepatocellular Carcinoma , , BELLEVUE,...ology, Inc. (LSO) today announced the completion o... Light Infusion Therapy(TM) (Litx(TM)) as a treatm...), also known as hepatoma or primary liver cancer....
(Date:11/24/2008)...swire/ -- Domino,s Pizza (NYSE: DPZ ), the,reco...up to raise dough for,the kids of St. Jude Childr...anks and Giving campaign. Domino,s customers will ...of purchase to benefit the children of St. Jude.,... or when ordering online at, www.dominos.com . Th...
(Date:11/24/2008)... leadership and long-term commitment to hepatitis ...ewswire-FirstCall/ -- Schering-Plough Corporation ... boceprevir, its lead investigational oral hepatit...elopment. The company believes boceprevir has the...s protease inhibitor for treating chronic hepatiti...
Breaking Medicine Technology:Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year End 2007 Financial Results 11912 1Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year End 2007 Financial Results 11912 2Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year End 2007 Financial Results 11912 3Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year End 2007 Financial Results 11912 4GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 11910 1GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 11910 2GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 11910 3GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers 11910 4Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results Teleconference and Webcast 3307 1Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results Teleconference and Webcast 3307 2Acute Coronary Events Drop After Italys Public Smoking Ban 11909 1Acute Coronary Events Drop After Italys Public Smoking Ban 11909 2
...., April 17, 2007,/PRNewswire-FirstCall/ -- Cell G...rom two previously conducted Phase 2 clinical tria...uation of antibody,responses in patients with adva... the GVAX cell-based immunotherapy induces,antibod...ssociated,antigens, including some not previously ...
...-Apr 17, 2007 - A 9-month, randomized,double-blin...mparing a 40 mg dose of COPAXONE(R) given daily to...wed a 38 percent greater,reduction in inflammatory...e images (MRI) of the brain. In addition, patients...an on-trial relapse rate,of 77 percent when compar...
Other Medicine Technology:Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 2Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 3Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 4Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 2Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 3Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 4Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 5
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
Medicine Products: